These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20679676)

  • 1. FDA approval does not mean what you think it does!
    Dorros G
    J Invasive Cardiol; 2010 Aug; 22(8):382-4. PubMed ID: 20679676
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions.
    Gentry G
    Food Drug Law J; 2009; 64(3):441-58. PubMed ID: 19999637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical device immunity: should promotion of off-label uses leave medical device manufacturers vulnerable to unlimited liability?
    Palmer PG
    J Leg Med; 2014; 35(4):553-77. PubMed ID: 25517635
    [No Abstract]   [Full Text] [Related]  

  • 6. Devices at heart of civil fraud suit.
    Scott L
    Mod Healthc; 1996 Jan; 26(4):21. PubMed ID: 10154131
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label Treatment in Otolaryngology-A Cautionary Tale.
    Rathi VK; Scangas GA; Gray ST
    JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):399-400. PubMed ID: 30946446
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA and the spine surgeon.
    Ducker TB
    J Spinal Disord; 1999 Aug; 12(4):277-9. PubMed ID: 10451041
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory affairs as they affect invasive cardiology.
    Fischell RE
    J Invasive Cardiol; 2001 Feb; 13(2):139-40; discussion 158-70. PubMed ID: 11176026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blind hog and the acorn: Medicare coverage for investigational devices.
    Betz R
    J Healthc Resour Manag; 1995 Mar; 13(3):31-2. PubMed ID: 10154864
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality and appropriateness of care: the response to allegations and actions needed by the cardiovascular professional.
    Brindis RG; Goldberg SD; Turco MA; Dean LS
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):2-4. PubMed ID: 21181966
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the U.S. Food and Drug Administration in device evaluation and monitoring.
    ; Diehl DL; Tierney WM; Adler DG; Conway JD; Farraye FA; Kantsevoy SV; Kaul V; Kethu SR; Kwon RS; Mamula P; Pedrosa MC; Rodriguez SA
    Gastrointest Endosc; 2010 Jul; 72(1):5-10. PubMed ID: 20421100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA a main culprit in delayed access to technology.
    Albertson D
    MLO Med Lab Obs; 1995 Aug; 27(8):23-4. PubMed ID: 10144934
    [No Abstract]   [Full Text] [Related]  

  • 15. Court rejects agency's investigational device payment policy. Cedars-Sinai Medical Center v. Shalala.
    Sutter RN
    Healthc Financ Manage; 1996 Jun; 50(6):98. PubMed ID: 10158247
    [No Abstract]   [Full Text] [Related]  

  • 16. Device battle continues. L.A. case sent back for statute of limitations ruling.
    Bellandi D
    Mod Healthc; 1997 Oct; 27(40):64. PubMed ID: 10173637
    [No Abstract]   [Full Text] [Related]  

  • 17. Off-label drug and device applications: meeting the challenge.
    Nahai F
    Aesthet Surg J; 2010; 30(3):485-6. PubMed ID: 20601583
    [No Abstract]   [Full Text] [Related]  

  • 18. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 19. New female condom clears FDA committee. Next for FDA review: package label and insert.
    AIDS Alert; 2009 Apr; 24(4):42-4. PubMed ID: 19382364
    [No Abstract]   [Full Text] [Related]  

  • 20. The hospital fraud inquiry that fizzled.
    Pound ET; Headden S
    US News World Rep; 1995 Dec; 119(24):42. PubMed ID: 10153026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.